94 related articles for article (PubMed ID: 16628829)
1. Controversial Chinese gene-therapy drug entering unfamiliar territory.
Jia H
Nat Rev Drug Discov; 2006 Apr; 5(4):269-70. PubMed ID: 16628829
[No Abstract] [Full Text] [Related]
2. Adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines.
Higuchi Y; Asaumi J; Murakami J; Wakasa T; Inoue T; Kuroda M; Shibuya K; Shigehara H; Kawasaki S; Fukui K; Kishi K; Hiraki Y
Oncol Rep; 2002; 9(6):1233-6. PubMed ID: 12375026
[TBL] [Abstract][Full Text] [Related]
3. Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neck.
Frank DK; Frederick MJ; Liu TJ; Clayman GL
Clin Cancer Res; 1998 Oct; 4(10):2521-8. PubMed ID: 9796986
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral p53 gene therapy in squamous cell cancer of the head and neck region.
Edelman J; Edelman J; Nemunaitis J
Curr Opin Mol Ther; 2003 Dec; 5(6):611-7. PubMed ID: 14755887
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.
Liu TJ; el-Naggar AK; McDonnell TJ; Steck KD; Wang M; Taylor DL; Clayman GL
Cancer Res; 1995 Jul; 55(14):3117-22. PubMed ID: 7606733
[TBL] [Abstract][Full Text] [Related]
6. Thermoradiotherapy combined with adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines.
Higuchi Y; Asaumi J; Murakami J; Matsuzaki H; Wakasa T; Inoue T; Konoucni H; Hisatomi M; Yanagi Y; Honda Y; Shigehara H; Kishi K
Oncol Rep; 2003; 10(2):415-20. PubMed ID: 12579282
[TBL] [Abstract][Full Text] [Related]
7. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.
Clayman GL; el-Naggar AK; Roth JA; Zhang WW; Goepfert H; Taylor DL; Liu TJ
Cancer Res; 1995 Jan; 55(1):1-6. PubMed ID: 7805018
[TBL] [Abstract][Full Text] [Related]
8. Effects of p53 gene therapy in radiotherapy or thermotherapy of human head and neck squamous cell carcinoma cell lines.
Higuchi Y; Asaumi J; Murakami J; Matsuzaki H; Wakasa T; Inoue T; Shigehara H; Konouchi H; Hisatomi M; Kawasaki S; Hiraki Y; Kishi K
Oncol Rep; 2003; 10(3):671-7. PubMed ID: 12684642
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effect of adenovirus-mediated transfer of the wild-type p53 gene with cisplatin].
Fujiwara T; Ogawa N; Kagawa S; Nishizaki M; Yasuda T; Tanaka N; Orita K; Roth JA
Gan To Kagaku Ryoho; 1996 Jul; 23(8):1085-8. PubMed ID: 8687228
[No Abstract] [Full Text] [Related]
10. [Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].
Zhang SW; Xiao SW; Liu CQ; Sun Y; Su X; Li DM; Xu G; Zhu GY; Xu B
Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):426-8. PubMed ID: 16188130
[TBL] [Abstract][Full Text] [Related]
11. Clinical trails referral resource. Clinical trials of adenovirus-p53 gene therapy.
Zwiebel JA; Nagler C; Smiley JK; Cheson BD
Oncology (Williston Park); 1998 Aug; 12(8):1172, 1175. PubMed ID: 11236309
[No Abstract] [Full Text] [Related]
12. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus.
Liu TJ; Zhang WW; Taylor DL; Roth JA; Goepfert H; Clayman GL
Cancer Res; 1994 Jul; 54(14):3662-7. PubMed ID: 8033080
[TBL] [Abstract][Full Text] [Related]
13. The current status of gene therapy.
Clayman GL
Semin Oncol; 2000 Aug; 27(4 Suppl 8):39-43. PubMed ID: 10952437
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of head and neck squamous cell carcinoma by recombinant adenovirus-p53 combined with radiotherapy: a phase II clinical trial of 42 cases].
Zhang SW; Xiao SW; Liu CQ; Sun Y; Su X; Li DM; Xu G; Cai Y; Zhu GY; Xu B; Lü YY
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2023-8. PubMed ID: 14703408
[TBL] [Abstract][Full Text] [Related]
15. Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials.
Overholt SM; Liu TJ; Taylor DL; Wang M; El-Naggar AK; Shillitoe E; Adler-Storthz K; John LS; Zhang WW; Roth JA; Clayman GL
Clin Cancer Res; 1997 Feb; 3(2):185-91. PubMed ID: 9815671
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model.
Eicher SA; Clayman GL; Liu TJ; Shillitoe EJ; Storthz KA; Roth JA; Lotan R
Clin Cancer Res; 1996 Oct; 2(10):1659-64. PubMed ID: 9816113
[TBL] [Abstract][Full Text] [Related]
17. Current role of gene therapy in head and neck cancer.
Ganly I; Soutar DS; Kaye SB
Eur J Surg Oncol; 2000 Jun; 26(4):338-43. PubMed ID: 10873352
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers.
Clayman GL; Frank DK; Bruso PA; Goepfert H
Clin Cancer Res; 1999 Jul; 5(7):1715-22. PubMed ID: 10430074
[TBL] [Abstract][Full Text] [Related]
19. Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk.
Morris JC; Wildner O
Mol Ther; 2000 Jan; 1(1):56-62. PubMed ID: 10933912
[TBL] [Abstract][Full Text] [Related]
20. All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma.
Nakashima T; Sun SY; Lotan R; Fujiwara T; Yasumatsu R; Komiyama S; Clayman GL
Laryngoscope; 2001 Aug; 111(8):1459-64. PubMed ID: 11568584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]